Problem: The COVID-19 pandemic drove a surge in global drug demand, but Indian pharma manufacturers struggled with unpredictable demand and supply chain disruptions in a tightly regulated environment. Frequent plan changes and imbalances in production loads further eroded efficiency, delayed deliveries, and pushed up costs. Solution: Adopt a flexible, dynamic manufacturing approach by decoupling procurement and quality control from forecasts. Implement full kits for production, prioritise orders by urgency, and dispense based on route load to optimise output. Benefits: This approach improves resource utilisation, reduces lead times, increases output, and enhances the ability to meet demand fluctuations, ensuring timely deliveries and better efficiency.

Key Takeaways

Can pharmaceutical giants address their unique operational challenges to help them be more flexible on the shop floor, discover hidden capacity, significantly increase output and respond quickly to changing market demands? They can, with a unique 'pull' based approach.

Accelerated pharma manufacturing

Problem: The COVID-19 pandemic drove a surge in global drug demand, but Indian pharmaceutical manufacturers struggled with unpredictable demand and supply chain disruptions in a tightly regulated environment. Frequent plan changes and imbalances in production loads further eroded efficiency, delayed deliveries, and pushed up costs. Solution: Adopt a flexible, dynamic manufacturing approach by decoupling procurement and quality control from forecasts. Implement full kits for production, prioritise orders by urgency, and dispense based on route load to optimise output. Benefits: This approach improves resource utilisation, reduces lead times, increases output, and enhances the ability to meet demand fluctuations, ensuring timely deliveries and better efficiency.

<h5>Accelerated pharma manufacturing</h5>

Download PDF

Explore strategies for accelerating pharmaceutical manufacturing amidst global demand surges and regulatory challenges with insights from Vector Consulting Group.